PCI Pharma Services: Press Releases

Major Manufacturing Expansion and $100 Million Investment at the Bedford, New Hampshire campus.
Tuesday, October 18, 2022 PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important...

Multi-Million Dollar Expansion to UK Manufacturing Facility
Tuesday, October 18, 2022 New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market.

Opening of World-Class Clinical Services Center of Excellence
Tuesday, October 18, 2022 PCI Pharma Services is today pleased to announce the opening of our new Clinical Services Center of Excellence in Bridgewater, MA, the first facility of its kind to support the...

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom
Thursday, June 16, 2022 SHORT HILLS, NJ. June 16, 2022--(BUSINESS WIRE)-- Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a late-stage clinical biopharmaceutical company focused on preventing and treating...

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.